Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Potent, selective human beta3-AR agonist characterized by Merck & Co.

April 6, 1999

Patent issued for new Merck glucagon antagonists

April 5, 1999

Inhibitors of the formation of AGTs described by Alteon

April 5, 1999

AMBI's Chromax demonstrates safety and efficacy in treatment of diabetes

April 5, 1999

Aradigm issued method patent for pulmonary insulin delivery

April 5, 1999

Merck develops potent, short-acting, orally active GH secretagogues

March 31, 1999

Potent new SERM related to raloxifene presented at ACS meeting by Lilly

March 31, 1999

Ono discloses PPARgamma modulators for metabolic disorders

March 31, 1999

Postmenopausal syndrome continues as focus of R&D at Lilly

March 31, 1999

Preclinical studies support BM-17.0744 as a potential treatment for metabolic syndrome

March 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...